PPD is the ideal consulting partner to assist with your biopharmaceutical product’s success from preclinical through post-approval.
Expedited recruitment, international regulatory expertise and operational teams trained in endocrine / metabolic indications.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
View all of PPD's news releases.
Workshop on Recent Issues in Bioanalysis (WRIB) is a large international conference attended by hundreds of people from pharmaceutical companies, biotechnology companies and contract research organizations. Bruce Stouffer, executive director of PPD® Laboratories bioanalytical lab, weighs in on his recent experiences at WRIB.
Chris Komelasky, a senior director of sites and patients, Rare Disease and Pediatric Center of Excellence, answers questions about his experiences at the World Orphan Drug Congress held in April.
Volker Hack, senior director and head of the project management standards group, and Denise Sackner, director of early development services standards, contribute their thoughts about three essentials for project management.
Steve Zdravkovic, a research scientist in the PPD® Laboratories GMP lab, writes about solid phase extraction (SPE) as an underutilized methodology.
Philip Bartle, an associate director in clinical innovation, discusses the use of industry data standards, which can greatly drive efficiencies and reduce variations in data.
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.